ACADIAN ASSET MANAGEMENT LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 1 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,753
-52.2%
2,927,769
+3.7%
0.01%
-53.3%
Q2 2023$3,665
+345.9%
2,821,980
+502.7%
0.02%
+275.0%
Q1 2023$822
-99.3%
468,239
+4617.8%
0.00%
Q1 2021$124,000
+19.2%
9,925
+48.5%
0.00%
Q4 2020$104,000
-84.5%
6,685
-85.1%
0.00%
-100.0%
Q3 2017$673,00044,8620.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders